Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Curaleaf Holdings Inc banner
C

Curaleaf Holdings Inc
CNSX:CURA

Watchlist Manager
Curaleaf Holdings Inc
CNSX:CURA
Watchlist
Price: 6.59 CAD 0.15% Market Closed
Market Cap: CA$4.8B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-
5Y
-
10Y
-
Investing Cash Flow
+
3Y
+41%
5Y
-
10Y
-
Financing Cash Flow
+
3Y
-
5Y
-
10Y
-

Cash Flow Statement
Curaleaf Holdings Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Operating Cash Flow
Net Income
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(62)
(73)
(97)
(104)
(70)
(74)
(52)
(53)
(57)
(59)
(66)
(117)
(215)
(114)
(132)
(128)
(377)
(402)
(442)
(451)
Depreciation & Amortization
0
0
0
0
0
0
0
0
9
15
24
35
37
46
57
71
80
95
110
123
121
143
151
158
164
168
179
181
Change in Deffered Taxes
0
0
0
0
0
0
0
0
2
4
3
7
7
8
13
21
12
6
13
(8)
(11)
23
5
2
(26)
(31)
(29)
(22)
Other Non-Cash Items
0
0
0
0
0
0
0
0
3
(11)
(27)
(56)
1
4
12
10
(59)
(46)
(39)
(11)
102
3
16
50
175
181
209
215
Cash Taxes Paid
0
0
0
0
0
0
0
0
1
0
0
3
7
0
0
24
21
22
104
85
92
94
119
129
156
155
84
81
Cash Interest Paid
0
0
0
0
0
0
0
0
5
2
5
5
9
15
23
33
38
30
21
43
33
33
51
23
79
80
81
78
Change in Working Capital
0
0
0
0
0
0
(0)
(0)
14
16
43
66
(14)
(7)
(26)
(74)
29
3
(115)
(2)
(56)
(25)
17
(18)
110
87
146
134
Cash from Operating Activities
(0)
N/A
(0)
+7%
(0)
+20%
(0)
+50%
(0)
+46%
(0)
-273%
(0)
-350%
(0)
+4%
(33)
-9 504%
(50)
-50%
(54)
-9%
(53)
+2%
(38)
+28%
(23)
+39%
5
N/A
(26)
N/A
4
N/A
(0)
N/A
(97)
-117 796%
(15)
+84%
(58)
-283%
29
N/A
57
+93%
65
+14%
46
-29%
3
-93%
62
+1 907%
57
-9%
Investing Cash Flow
Capital Expenditures
(0)
0
0
0
0
0
0
0
(46)
(64)
(89)
(113)
(82)
(86)
(91)
(85)
(126)
(135)
(148)
(173)
(172)
(170)
(159)
(154)
(138)
(134)
(113)
(90)
Other Items
0
0
0
0
0
0
0
0
(88)
(146)
(181)
(200)
(122)
(86)
(94)
(110)
(71)
(49)
34
66
8
(59)
(102)
(101)
(90)
(27)
(24)
(25)
Cash from Investing Activities
(0)
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(134)
N/A
(211)
-57%
(270)
-28%
(313)
-16%
(204)
+35%
(173)
+15%
(185)
-7%
(196)
-6%
(197)
-1%
(184)
+7%
(114)
+38%
(108)
+6%
(164)
-52%
(229)
-40%
(260)
-14%
(255)
+2%
(229)
+10%
(161)
+29%
(137)
+15%
(115)
+16%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
404
402
402
403
2
3
3
27
28
269
270
246
244
2
(0)
(2)
(1)
(1)
0
0
Net Issuance of Debt
0
0
0
0
0
0
0
0
75
77
75
75
16
174
168
152
199
9
25
32
150
84
103
106
(9)
(24)
(84)
(79)
Other
0
0
0
0
0
0
0
0
(67)
(67)
(67)
(41)
(0)
22
0
33
(3)
42
126
79
55
43
(41)
(30)
60
60
58
56
Cash from Financing Activities
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
+71%
0
-6%
413
+106 780%
412
0%
411
0%
436
+6%
18
-96%
200
+1 005%
195
-2%
215
+10%
224
+4%
322
+44%
421
+31%
357
-15%
449
+26%
130
-71%
62
-52%
74
+20%
51
-32%
35
-31%
(27)
N/A
(23)
+14%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
(1)
(2)
(5)
(3)
(4)
(4)
(1)
1
Net Change in Cash
(0)
N/A
(0)
+7%
(0)
+20%
(0)
+50%
(0)
+47%
0
N/A
0
-69%
0
-16%
246
+588 219%
151
-38%
86
-43%
70
-19%
(224)
N/A
4
N/A
15
+312%
(7)
N/A
31
N/A
138
+343%
211
+53%
233
+10%
226
-3%
(72)
N/A
(147)
-104%
(120)
+19%
(136)
-14%
(127)
+7%
(102)
+19%
(80)
+22%
Free Cash Flow
Free Cash Flow
(0)
N/A
(0)
+7%
(0)
+20%
(0)
+50%
(0)
+46%
(0)
-273%
(0)
-350%
(0)
+4%
(79)
-22 809%
(114)
-44%
(143)
-26%
(166)
-16%
(120)
+27%
(110)
+9%
(86)
+22%
(111)
-30%
(122)
-9%
(135)
-11%
(245)
-81%
(189)
+23%
(230)
-22%
(141)
+39%
(102)
+28%
(89)
+13%
(92)
-4%
(131)
-43%
(51)
+61%
(33)
+35%

See Also

Summary
CURA intrinsic value, competitors valuation, and company profile.
DCF Valuation
CURA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CURA stock valuation using valuation multiples.
Wall Street Estimates
CURA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CURA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.